enGene Holdings Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: ENGNW · Form: 8-K · Filed: Oct 25, 2024 · CIK: 1980845
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
TL;DR
enGene Holdings Inc. filed an 8-K detailing a material definitive agreement and unregistered equity sales.
AI Summary
On October 24, 2024, enGene Holdings Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for enGene Holdings Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- enGene Holdings Inc. (company) — Registrant
- October 24, 2024 (date) — Date of earliest event reported
- 4868 Rue Levy, Suite 220 (address) — Principal Executive Office Address
- Saint-Laurent, Quebec, Canada (location) — Principal Executive Office Location
FAQ
What is the nature of the material definitive agreement entered into by enGene Holdings Inc. on October 24, 2024?
The filing states that enGene Holdings Inc. entered into a material definitive agreement on October 24, 2024, but the specific details of this agreement are not provided in the summary information.
What type of equity securities were sold in the unregistered sales reported by enGene Holdings Inc.?
The filing mentions unregistered sales of equity securities, but the specific type of securities is not detailed in the provided summary.
What is the primary business of enGene Holdings Inc. according to the SIC code?
According to the Standard Industrial Classification code provided (2836), enGene Holdings Inc. is involved in Biological Products (No Diagnostic Substances).
When is enGene Holdings Inc.'s fiscal year end?
enGene Holdings Inc.'s fiscal year ends on October 31st.
What is the Commission File Number for enGene Holdings Inc.?
The Commission File Number for enGene Holdings Inc. is 001-41854.
Filing Stats: 1,258 words · 5 min read · ~4 pages · Grade level 13.7 · Accepted 2024-10-25 08:10:33
Key Financial Figures
- $11.50 — e common share, at an exercise price of $11.50 per share ENGNW The Nasdaq Stock Ma
- $8.90 — e " Subscribed Shares "), at a price of $8.90 per share. The aggregate gross proceeds
- $60 m — cement are expected to be approximately $60 million, before deducting offering expens
Filing Documents
- d863566d8k.htm (8-K) — 35KB
- d863566dex101.htm (EX-10.1) — 227KB
- d863566dex991.htm (EX-99.1) — 10KB
- d863566dex992.htm (EX-99.2) — 44KB
- g863566dsp76.jpg (GRAPHIC) — 6KB
- g863566ex99_2s10g1.jpg (GRAPHIC) — 64KB
- g863566ex99_2s11g1.jpg (GRAPHIC) — 86KB
- g863566ex99_2s12g1.jpg (GRAPHIC) — 81KB
- g863566ex99_2s13g1.jpg (GRAPHIC) — 61KB
- g863566ex99_2s14g1.jpg (GRAPHIC) — 53KB
- g863566ex99_2s15g1.jpg (GRAPHIC) — 84KB
- g863566ex99_2s16g1.jpg (GRAPHIC) — 80KB
- g863566ex99_2s17g1.jpg (GRAPHIC) — 91KB
- g863566ex99_2s18g1.jpg (GRAPHIC) — 86KB
- g863566ex99_2s19g1.jpg (GRAPHIC) — 94KB
- g863566ex99_2s1g1.jpg (GRAPHIC) — 32KB
- g863566ex99_2s20g1.jpg (GRAPHIC) — 82KB
- g863566ex99_2s21g1.jpg (GRAPHIC) — 63KB
- g863566ex99_2s22g1.jpg (GRAPHIC) — 95KB
- g863566ex99_2s23g1.jpg (GRAPHIC) — 92KB
- g863566ex99_2s24g1.jpg (GRAPHIC) — 109KB
- g863566ex99_2s25g1.jpg (GRAPHIC) — 100KB
- g863566ex99_2s26g1.jpg (GRAPHIC) — 87KB
- g863566ex99_2s27g1.jpg (GRAPHIC) — 29KB
- g863566ex99_2s28g1.jpg (GRAPHIC) — 135KB
- g863566ex99_2s2g1.jpg (GRAPHIC) — 252KB
- g863566ex99_2s3g1.jpg (GRAPHIC) — 87KB
- g863566ex99_2s4g1.jpg (GRAPHIC) — 98KB
- g863566ex99_2s5g1.jpg (GRAPHIC) — 68KB
- g863566ex99_2s6g1.jpg (GRAPHIC) — 91KB
- g863566ex99_2s7g1.jpg (GRAPHIC) — 65KB
- g863566ex99_2s8g1.jpg (GRAPHIC) — 91KB
- g863566ex99_2s9g1.jpg (GRAPHIC) — 94KB
- 0001193125-24-243481.txt ( ) — 3942KB
- engn-20241024.xsd (EX-101.SCH) — 3KB
- engn-20241024_def.xml (EX-101.DEF) — 14KB
- engn-20241024_lab.xml (EX-101.LAB) — 23KB
- engn-20241024_pre.xml (EX-101.PRE) — 14KB
- d863566d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Form of Subscription Agreement, dated October 24, 2024 99.1 Press Release dated October 25, 2024 99.2 Corporate Presentation dated October 25, 2024 104 Cover Page Interactive Data File (Formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENGENE HOLDINGS INC. Date: October 25, 2024 By: /s/ Lee Giguere Name: Lee Giguere Title: Chief Legal Officer